Earnings Reports

ED Stock Earnings: Consolidated Edison Beats EPS, Misses Revenue for Q1 2024

ED stock results show that Consolidated Edison beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

POST Stock Earnings: Post Hldgs Beats EPS, Misses Revenue for Q2 2024

POST stock results show that Post Hldgs beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

GORO Stock Earnings: Gold Resource Meets EPS, Beats Revenue for Q1 2024

GORO stock results show that Gold Resource met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

AES Stock Earnings: AES Beats EPS, Misses Revenue for Q1 2024

AES stock results show that AES beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

TRGP Stock Earnings: Targa Resources Misses EPS, Beats Revenue for Q1 2024

TRGP stock results show that Targa Resources missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

FRT Stock Earnings: Federal Realty Investment Misses EPS, Beats Revenue for Q1 2024

FRT stock results show that Federal Realty Investment missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

TWST Stock Earnings: Twist Bioscience Beats EPS, Beats Revenue for Q2 2024

TWST stock results show that Twist Bioscience beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

MX Stock Earnings: MagnaChip Semiconductor Beats EPS, Beats Revenue for Q1 2024

MX stock results show that MagnaChip Semiconductor beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

XHR Stock Earnings: Xenia Hotels & Resorts Beats EPS, Beats Revenue for Q1 2024

XHR stock results show that Xenia Hotels & Resorts beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

REZI Stock Earnings: Resideo Technologies Beats EPS, Misses Revenue for Q1 2024

REZI stock results show that Resideo Technologies beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

AMGN Stock Earnings: Amgen Beats EPS, Beats Revenue for Q1 2024

AMGN stock results show that Amgen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

LXRX Stock Earnings: Lexicon Pharmaceuticals Meets EPS, Misses Revenue for Q1 2024

LXRX stock results show that Lexicon Pharmaceuticals met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

CERS Stock Earnings: Cerus Meets EPS, Misses Revenue for Q1 2024

CERS stock results show that Cerus met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

CLFD Stock Earnings: Clearfield Beats EPS, Beats Revenue for Q2 2024

CLFD stock results show that Clearfield beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

ALHC Stock Earnings: Alignment Healthcare Misses EPS, Beats Revenue for Q1 2024

ALHC stock results show that Alignment Healthcare missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

AAON Stock Earnings: AAON Meets EPS, Misses Revenue for Q1 2024

AAON stock results show that AAON met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

TWOU Stock Earnings: 2U Beats EPS, Beats Revenue for Q1 2024

TWOU stock results show that 2U beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

SXI Stock Earnings: Standex International Beats EPS, Misses Revenue for Q3 2024

SXI stock results show that Standex International beat analyst estimates for earnings per share but missed on revenue for the third quarter of 2024.

RARE Stock Earnings: Ultragenyx Pharmaceutical Misses EPS, Misses Revenue for Q1 2024

RARE stock results show that Ultragenyx Pharmaceutical missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.